
Meditrax S 500mg/250mg Injection
Marketer
Puremed Biotech
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Meditrax S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this injection solely under a physician's guidance; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, regardless of symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately. Seek immediate medical attention for allergic reactions (skin rashes, itching, edema, dyspnea). Inform your doctor about all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing to driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and hydration contribute to faster recovery. Your doctor may order blood tests and other diagnostic assessments to monitor treatment response.
Primary Ingredients of Meditrax S 500mg/250mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Meditrax S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Meditrax S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Meditrax S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Meditrax S 500mg/250mg Injection:
Administering this medication will be done by your physician or their qualified assistant. Self-medication is strongly discouraged.
How Meditrax S 500mg/250mg Injection works:
Ceftriaxone and Sulbactam, combined as Meditrax S 500mg/250mg Injection, offer a dual-action antibacterial approach. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Meditrax S 500mg/250mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Meditrax S (500mg/250mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or absent harm to the fetus; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
Administering Meditrax S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Meditrax S 500mg/250mg Injection may induce drowsiness, blurred vision, and dizziness. Refrain from operating vehicles if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Meditrax S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Meditrax S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Meditrax S 500mg/250mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Meditrax S 500mg/250mg Injection :
Should you inadvertently skip a Meditrax S 500mg/250mg Injection, seek your physician's advice.
Facts to Know About Meditrax S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
